Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06534918 · ClinicalTrials.gov registry record · NA
Precise Oncology Interventions in Nutrition and Training (OnPoint)
A NA study of Breast Cancer and Prostate Cancer, sponsored by University of Miami.
- Recruiting
- Registry status
- NA
- Development phase
- 306
- Enrollment target
- 1
- Study location
NCT06534918: Recruiting NA study of Breast Cancer and Prostate Cancer, sponsored by University of Miami.
NCT06534918 is a NA study of Breast Cancer and Prostate Cancer that is actively recruiting participants, run by University of Miami. The registered enrollment target is 306 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06534918, a NA study of Breast Cancer and Prostate Cancer, is actively recruiting participants, sponsored by University of Miami.
- RECRUITING
- Registry status
- NA
- Development phase
- 306 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to see if survivors of breast, prostate, or colorectal cancer who receive a personal referral to a targeted nutrition and exercise program will be able to eat a healthier diet and be more physically activity.
Primary Outcome
Percentage of survivors who agree to participate will be reported as ≥ 50%.
Conditions Studied
Interventions
- OTHER Fitbit
- BEHAVIORAL Nutrition Course: Group Sessions
- BEHAVIORAL Physical Activity Program: Group Sessions
- BEHAVIORAL Nutrition Course: One on One Sessions with Registered Dietitian
- BEHAVIORAL Physical Activity Program: One on One Sessions with an Exercise Physiologist
Study Locations (1)
Florida
- University of Miami - Miami
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 306 participants |
| Start Date | 2024-09-18 |
| Est. Completion | 2027-09-30 |
| Phase | NA |
What NCT06534918 shows while recruiting
NCT06534918 is an interventional study that assigns participants to a tested intervention. The registered 306 participants enrollment target is mid-sized for trials with a published cap, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (89% lower).
The record links to 3 conditions, with Breast Cancer appearing as the primary indexed condition, and to 5 interventions - of which Fitbit is the first listed.
NCT06534918 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT06534918 about?
NCT06534918 is a clinical study titled "Precise Oncology Interventions in Nutrition and Training (OnPoint)". The purpose of this study is to see if survivors of breast, prostate, or colorectal cancer who receive a personal referral to a targeted nutrition and exercise program will be able to eat a healthier diet and be more physically activity.
What is the current status of trial NCT06534918?
This trial is currently recruiting. It is a NA study. The enrollment target is 306 participants. The study started on 2024-09-18. Estimated completion is 2027-09-30.
What conditions does trial NCT06534918 study?
This clinical trial studies the following conditions: Breast Cancer, Prostate Cancer, Colorectal Cancer.
What interventions are being tested in trial NCT06534918?
The interventions under investigation include: Fitbit (OTHER), Nutrition Course: Group Sessions (BEHAVIORAL), Physical Activity Program: Group Sessions (BEHAVIORAL), Nutrition Course: One on One Sessions with Registered Dietitian (BEHAVIORAL), Physical Activity Program: One on One Sessions with an Exercise Physiologist (BEHAVIORAL).
Who is sponsoring clinical trial NCT06534918?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06534918 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06534918's enrollment target sits among peer trials
306 273rd of 1224 higher than 952 of 1,224 other Breast Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Breast Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
-
Resistance and Aerobic Exercise for Prevention in Women With Dense Breasts (REP-D)
RECRUITING · NA
-
Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)
RECRUITING · NA
-
A Randomized Controlled Trial (RCT) to Determine the Efficacy of a Multidisciplinary CBT Based Pain Management Program for the Treatment of Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS) in Breast Cancer Survivors
RECRUITING · NA
-
Improving Comprehensive Care of Cancer Patients
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05078970 · 306 participants · NA
Advancing Suicide Intervention Strategies for Teens During High Risk Periods
- NCT05843695 · 306 participants · NA
Enhancing Psychotherapy for Veterans and Service Members With PTSD and Anxiety
- NCT06057337 · 306 participants · NA
Families With Pride ("Familias Con Orgullo").
- NCT06498635 · 306 participants · Phase 3
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI